相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Don't Forget HPV-45 in Cervical Cancer Screening
Wiebren A. A. Tjalma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Genotyping of human papillomavirus in triaging of low-grade cervical cytology
Anna Soderlund-Strand et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study
Mark Schiffman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study
Koji Matsumoto et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication
Ni Li et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine
Kevin A. Ault et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting
F. M. Carozzi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer
Hui-Chi Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E. Castle et al.
LANCET ONCOLOGY (2011)
Clinical validation of the Cervista® HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology
Mark H. Einstein et al.
GYNECOLOGIC ONCOLOGY (2010)
Feasibility Study of a Human Papillomavirus E6 Oncoprotein Test for Diagnosis of Cervical Precancer and Cancer
Johannes Schweizer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings
Laia Bruni et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
Susanne K. Kjaer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants
Sophia S. Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
Pontus Naucler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparison of the performance of different HPV genotyping methods for detecting genital HPV types
Stefanie J. Klug et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China
You-lin Qiao et al.
LANCET ONCOLOGY (2008)
Members of the human papillornavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix
Gary Clifford et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
N. W. J. Bulkmans et al.
LANCET (2007)
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
Jennifer S. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
HPV type-specific risks of high-grade CIN during 4 years of follow-up:: A population-based prospective study
P. Naucler et al.
BRITISH JOURNAL OF CANCER (2007)
The carcinogenicity of human papillornavirus types reflects viral evolution
M Schiffman et al.
VIROLOGY (2005)
Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer.
GM Clifford et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
GM Clifford et al.
BRITISH JOURNAL OF CANCER (2003)
Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis
GM Clifford et al.
BRITISH JOURNAL OF CANCER (2003)
A note on robust variance estimation for cluster-correlated data
RL Williams
BIOMETRICS (2000)